JB
Jason Bednar Piper Sandler Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
50
Avg Return
Past Year
Past Year
1.2%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
77.8%
Neutral
22.2%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Diagnostics & Research
Medical Devices
Medical Distribution
Medical Instruments & Supplies
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Overweight
Initiated
| $50 |
13%
upside
| 1 | +8.9% |
0
%
| 12 Jan ‘26 6 days ago |
|
|
|
Overweight
Upgraded
| $24 |
25%
upside
| 2 | +2% |
0
%
| 9 Jan ‘26 9 days ago |
|
|
|
Overweight
Reiterated
| $94 |
14%
upside
| 1 | -2.1% |
0
%
| 5 Dec ‘25 1 month ago |
|
|
|
Neutral
Maintained
| $190 |
8%
downside
| 1 | -17% |
0
%
| 7 Nov ‘25 2 months ago |
|
|
|
Overweight
Maintained
| $172 |
10%
upside
| 1 | +12% |
0
%
| 7 Nov ‘25 2 months ago |
|
|
|
Overweight
Maintained
| $98 |
23%
upside
| 1 | +3% |
0
%
| 7 Nov ‘25 2 months ago |
|
|
|
Overweight
Reiterated
| $109 |
32%
upside
| 1 | -2.8% |
0
%
| 31 Oct ‘25 2 months ago |
|
|
|
Overweight
Reiterated
| $200 |
17%
upside
| 1 | -1.4% |
0
%
| 30 Oct ‘25 2 months ago |
|